Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally

NCT00489931 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

NIH

Sponsor class

Conditions

Influenza A Virus, H5N1 Subtype
Influenza A Virus
Influenzavirus A
Orthomyxovirdae
H5N1 Virus

Interventions

DRUG: VRC-AVIDNA036-00-VP

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)